Taysha Gene Therapies, Inc. TSHA Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s operating lease ROU assets?
- Taysha Gene Therapies, Inc. (TSHA) reported operating lease ROU assets of $9.16M in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s operating lease ROU assets changed year-over-year?
- Taysha Gene Therapies, Inc.'s operating lease ROU assets increased by 13.3% year-over-year, from $8.08M to $9.16M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s operating lease ROU assets?
- Over 3 years (2022 to 2025), Taysha Gene Therapies, Inc.'s operating lease ROU assets has grown at a -4.8% compound annual growth rate (CAGR), from $10.94M to $9.44M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.